USPTO serial 79060247
ANGIOCYCLIC
Reviewed by CopyMark Law Group
Reg. 3784899Status 404
- Filing date
- Status date
- Registration date
- May 4, 2010
- Examiner
- LOWRY, LEIGH A
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with ANGIOCYCLIC?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Diane Donnelly
Diane Donnelly von MALTITZ, DERENBERG, KUNIN, JANSSEN &60 East 42nd StreetNEW YORK, NY 10165UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | PHARMACEUTICAL PREPARATIONS AND SUBSTANCES FOR THE PREVENTION AND TREATMENT OF PROLIFERATIVE DISORDERS, NAMELY, HUMAN CANCERS, INFLAMMATORY KIDNEY DISEASES, HIV, AIDS, AND DIABETES; BIOPHARMACEUTICAL PREPARATIONS AND SUBSTANCES FOR THE PREVENTION AND TREATMENT OF PROLIFERATIVE DISORDERS, NAMELY, HUMAN CANCERS, INFLAMMATORY KIDNEY DISEASES, HIV, AIDS, AND DIABETES; CHEMICAL PREPARATIONS AND SUBSTANCES FOR PHARMACEUTICAL, BIOPHARMACEUTICAL AND MEDICAL PURPOSES FOR THE PREVENTION AND TREATMENT OF PROLIFERATIVE DISORDERS, NAMELY, HUMAN CANCERS, INFLAMMATORY KIDNEY DISEASES, HIV, AIDS, AND DIABETES; DRUGS FOR THE PREVENTION AND TREATMENT OF PROLIFERATIVE DISORDERS, NAMELY, HUMAN CANCERS, INFLAMMATORY KIDNEY DISEASES, HIV, AIDS, AND DIABETES; DRUGS FOR MEDICAL PURPOSES FOR THE PREVENTION AND TREATMENT OF PROLIFERATIVE DISORDERS, NAMELY, HUMAN CANCERS, INFLAMMATORY KIDNEY DISEASES, HIV, AIDS, AND DIABETES; MEDICAL THERAPEUTIC DRUGS FOR THE PREVENTION AND TREATMENT OF PROLIFERATIVE DISORDERS, NAMELY, HUMAN CANCERS, INFLAMMATORY KIDNEY DISEASES, HIV, AIDS, AND DIABETES | SECTION 71 - CANCELLED | — |
| 041 | EDUCATIONAL SERVICES, NAMELY, PROVIDING CLASSES, SEMINARS, LECTURES AND COMPUTER EDUCATION TRAINING, ALL RELATING TO SCIENTIFIC RESEARCH, MEDICAL RESEARCH, DRUG RESEARCH AND DRUG DEVELOPMENT TECHNOLOGY IN THE FIELDS OF ONCOLOGY, NEPHROLOGY, AND TREATMENTS FOR PROLIFERATIVE DISORDERS, HIV, AIDS, AND DIABETES; EDUCATIONAL SERVICES, NAMELY, PROVIDING CLASSES, SEMINARS, LECTURES AND COMPUTER EDUCATION TRAINING FOR THE COMPILATION OF SCIENTIFIC INFORMATION AND USE OF SCIENTIFIC MATERIALS FROM DATABASES IN THE FIELDS OF ONCOLOGY, NEPHROLOGY, AND TREATMENTS FOR PROLIFERATIVE DISORDERS, HIV, AIDS, AND DIABETES | SECTION 71 - CANCELLED | — |
| 042 | SCIENTIFIC RESEARCH SERVICES AND LABORATORY RESEARCH SERVICES IN THE FIELDS OF ONCOLOGY, NEPHROLOGY, AND TREATMENTS FOR PROLIFERATIVE DISORDERS, HIV, AIDS, AND DIABETES; COMPILATION OF SCIENTIFIC INFORMATION FOR SCIENTIFIC OR FOR SCIENTIFIC RESEARCH SERVICES IN THE FIELDS OF ONCOLOGY, NEPHROLOGY, AND TREATMENTS FOR PROLIFERATIVE DISORDERS, HIV, AIDS, AND DIABETES; MEDICAL RESEARCH AND LABORATORY RESEARCH SERVICES IN THE FIELDS OF ONCOLOGY, NEPHROLOGY, AND TREATMENTS FOR PROLIFERATIVE DISORDERS, HIV, AIDS, AND DIABETES; PROVIDING ONLINE SCIENTIFIC INFORMATION IN THE FIELDS OF ONCOLOGY, NEPHROLOGY, AND TREATMENTS FOR PROLIFERATIVE DISORDERS, HIV, AIDS, AND DIABETES; DRUG RESEARCH SERVICES IN THE FIELDS OF ONCOLOGY, NEPHROLOGY, AND TREATMENTS FOR PROLIFERATIVE DISORDERS, HIV, AIDS, AND DIABETES; DEVELOPMENT OF PHARMACEUTICAL DRUGS, DRUGS FOR MEDICAL PURPOSES AND MEDICAL THERAPEUTIC DRUGS | SECTION 71 - CANCELLED | — |
| 044 | MEDICAL SERVICES; COMPILATION OF MEDICAL, PHARMACEUTICAL AND BIOPHARMACEUTICAL INFORMATION FOR DIAGNOSTIC PURPOSES AND EXCLUDING MEDICAL, PHARMACEUTICAL AND BIOPHARMACEUTICAL RESEARCH INFORMATION; AND PROVIDING ONLINE MEDICAL, PHARMACEUTICAL AND BIOPHARMACEUTICAL INFORMATION FOR DIAGNOSTIC PURPOSES | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Cyclacel Limited
- Other trademarks owned by Cyclacel Limited
- Other trademarks owned by Cyclacel Limited
- Other trademarks in Class 005
- Other trademarks in Class 041
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named ANGIOCYCLIC
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 2, 2019 | DENC | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED | — |
| May 2, 2019 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Mar 30, 2018 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Sep 8, 2017 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| Aug 15, 2017 | INTS | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Aug 15, 2017 | INPC | INVALIDATION PROCESSED | — |
| Aug 9, 2017 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Dec 9, 2016 | C71T | CANCELLED SECTION 71 | — |
| Feb 5, 2013 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Aug 13, 2010 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Aug 13, 2010 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Aug 4, 2010 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| May 4, 2010 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Apr 30, 2010 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Apr 15, 2010 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Apr 15, 2010 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Feb 16, 2010 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Feb 16, 2010 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jan 13, 2010 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Jan 12, 2010 | ALIE | ASSIGNED TO LIE | — |
| Jan 8, 2010 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 7, 2009 | ACEC | AMENDMENT FROM APPLICANT ENTERED | — |
| Dec 7, 2009 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 3, 2009 | PAPER RECEIVED | — | |
| Jun 29, 2009 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Jun 29, 2009 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jun 29, 2009 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jun 5, 2009 | ACEC | AMENDMENT FROM APPLICANT ENTERED | — |
| Jun 5, 2009 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 1, 2009 | ALIE | ASSIGNED TO LIE | — |
| May 29, 2009 | PAPER RECEIVED | — | |
| Feb 5, 2009 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jan 5, 2009 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jan 5, 2009 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jan 1, 2009 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Dec 31, 2008 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 30, 2008 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 18, 2008 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Nov 14, 2008 | NWAP | NEW APPLICATION ENTERED | — |
| Nov 13, 2008 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |